Description
CATH SELF CATH 14FR 450 MEN 50
First action · last action
2011-12-20 · 2016-04-11
Transactions
2
First transaction's obligation
$9,925
Base + all options value (sum of deltas)
$1,590
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
424210 · DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-12-20+$9,925= $9,925
- Mod P000012016-04-11-$8,335= $1,590
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-12-20 | +$9,925 | $9,925 | CATH SELF CATH 14FR 450 MEN 50 |
| Mod P00001· CLOSE OUT | 2016-04-11 | −$8,335 | $1,590 | CATH SELF CATH 14FR 450 MEN 50 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JGBBJDD1ZR23)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA25713C0089 | 257-NETWORK CONTRACT OFFICE 17 · 6505 · DRUGS AND BIOLOGICALS | $28,472 | FY2013 |
| VA24813P0483 | 248-NETWORK CONTRACT OFFICE 8 · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $6,721 | FY2013 |
| VA25712P1242 | 257-NETWORK CONTRACT OFFICE 17 · 6509 · DRUGS AND BIOLOGICALS, VETERINARY USE | $3,774 | FY2012 |
| VA69312P0505 | 693-WILKES-BARRE · 6505 · DRUGS AND BIOLOGICALS | $9,197 | FY2012 |
| VA24412P2416 | 693-WILKES-BARRE · 6505 · DRUGS AND BIOLOGICALS | $15,108 | FY2012 |
| VA24812P4594 | 673-TAMPA · 6505 · DRUGS AND BIOLOGICALS | $25,551 | FY2012 |
Other recipients under 6515 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826P1275 | ENCORE MEDICAL, L.P. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $9,800 | FY2026 |
| 36C24826N0893 | GLOMAX, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $309,731 | FY2026 |
| 36C24826N0898 | ENCORE MEDICAL, L.P. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $13,348 | FY2026 |
| 36C24826N0895 | PERMOBIL INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $18,598 | FY2026 |
| 36C24826N0860 | DISORB SYSTEMS INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $49,238 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24812P0806_3600_-NONE-_-NONE- · retrieved 2026-09-26.